N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143124 |
| CAS No | NA |
| Mol.F. | C28H24N4O6 |
| Mol.Wt. | 512.52 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143125 |
| CAS No | NA |
| Mol.F. | C36H29N5O9 |
| Mol.Wt. | 675.65 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143126 |
| CAS No | NA |
| Mol.F. | C17H14FN3O4 |
| Mol.Wt. | 343.31g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143127 |
| CAS No | NA |
| Mol.F. | C23H21N3O7 |
| Mol.Wt. | 451.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143128 |
| CAS No | NA |
| Mol.F. | C28H23FN4O7 |
| Mol.Wt. | 546.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143129 |
| CAS No | NA |
| Mol.F. | C28H23ClN4O6 |
| Mol.Wt. | 520.93 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143130 |
| CAS No | NA |
| Mol.F. | C22H26N2O5 |
| Mol.Wt. | 398.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143131 |
| CAS No | NA |
| Mol.F. | C22H25FN2O5 |
| Mol.Wt. | 416.45 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143132 |
| CAS No | NA |
| Mol.F. | C22H24F2N2O5 |
| Mol.Wt. | 434.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143133 |
| CAS No | NA |
| Mol.F. | C7H12N2O4 |
| Mol.Wt. | 188.18 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143134 |
| CAS No | NA |
| Mol.F. | C29H52N2O6 |
| Mol.Wt. | 524.74 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143135 |
| CAS No | NA |
| Mol.F. | C37H63N3O6 |
| Mol.Wt. | 645.93 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143136 |
| CAS No | NA |
| Mol.F. | C8H15N3O5 |
| Mol.Wt. | 233.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143137 |
| CAS No | NA |
| Mol.F. | C16H17ClN2O2 |
| Mol.Wt. | 304.77 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143138 |
| CAS No | NA |
| Mol.F. | C17H17N5O2S |
| Mol.Wt. | 355.42 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143139 |
| CAS No | NA |
| Mol.F. | C12H10N4OS |
| Mol.Wt. | 258.30 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |